Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Muscle-driven gene therapy shows promise for protecting memory in Alzheimer’s

Alzheimer's disease (AD) is a devastating cause of memory loss and cognitive decline, for which no curative treatment is available.

18 Nov 2025

Scottish Brain Sciences opens new Alzheimer’s clinical research center at ONE Biohub

Scottish Brain Sciences (SBS), a leading clinical research organization dedicated to transforming the early detection and treatment of Alzheimer's disease and other neurodegenerative conditions, today announced that it has opened a new state-of-the-art clinical research center at ONE BioHub, Aberdeen.

17 Nov 2025

Hypertension may induce early gene expression changes in brain cells

Hypertension impairs blood vessels, neurons and white matter in the brain well before the condition causes a measurable rise in blood pressure, according to a new preclinical study from Weill Cornell Medicine investigators.

14 Nov 2025

New insights into glioblastoma survival linked to brain fluid dynamics

Glioblastoma-the most aggressive form of brain cancer-remains one of medicine's biggest challenges. Despite surgery, radiotherapy, and chemotherapy, most patients survive only about a year after diagnosis.

14 Nov 2025

Empowering early detection of dementia with a dual approach involving AI and patient input

Few primary care practices are designed for the timely detection of Alzheimer's disease and related dementias. The limited time that primary care clinicians are able to spend with patients, the need to focus on the health problems which brought the patient to the clinic, as well as the stigma of Alzheimer's disease and dementia are major reasons for lack of recognition of the condition.

13 Nov 2025

New Mayo Clinic tool predicts Alzheimer’s risk years before symptoms begin

Mayo Clinic researchers have developed a new tool that can estimate a person's risk of developing memory and thinking problems associated with Alzheimer's disease years before symptoms appear.

12 Nov 2025

What the air you breathe may be doing to your brain

For years, the two patients had come to the Penn Memory Center at the University of Pennsylvania, where doctors and researchers follow people with cognitive impairment as they age, as well as a group with normal cognition.

12 Nov 2025

Amyloid-clearing drug fails to change waste clearance function in the brains of Alzheimer's patients

A group from Osaka Metropolitan University in Japan, led by graduate student Tatsushi Oura and Dr. Hiroyuki Tatekawa, found that treatment using the drug lecanemab to remove amyloid plaques in the brain does not change the waste clearance function in the brains of Alzheimer's disease (AD) patients in the short term.

11 Nov 2025

Midlife blood test may reveal Alzheimer’s disease risk in advance

A simple blood test for platelet activity at middle age could one day help identify people at risk for Alzheimer's disease decades ahead of time, allowing for possible preventive therapy.

11 Nov 2025

Shared genetic roots connect neurological and psychiatric disorders

In a groundbreaking study, researchers from the Centre for Precision Psychiatry at the University of Oslo and Oslo University Hospital have discovered extensive genetic links between neurological disorders like migraine, stroke and epilepsy, and psychiatric illnesses such as schizophrenia and depression.

11 Nov 2025

Targeting RNA splicing errors protects against tau-induced neurodegeneration

Alzheimer's Disease (AD), the leading cause of dementia, affects nearly 40 million individuals globally, resulting in a gradual loss of memory and independence. Despite extensive research over the past decades, no treatments have been found that can halt or reverse the progression of this devastating disease.

11 Nov 2025

Scientists pinpoint a reason Alzheimer’s patients forget loved ones

One of the most devastating moments for family members of a patient with Alzheimer's is when their loved one forgets who they are. New University of Virginia School of Medicine research may explain why that happens and could lead to a way to prevent it.

10 Nov 2025

New diagnostic approach identifies dementia stages based on neurovascular and metabolic changes

Researchers from the Indiana University School of Medicine have developed a highly sensitive diagnostic that predicts a person's stage of dementia based on neurovascular and metabolic changes.

10 Nov 2025

Newly identified microglia subtype offers protection against Alzheimer’s disease

In Alzheimer's disease, the leading cause of dementia, microglia-the brain's immune defenders-can act as both protectors and aggressors, shaping how the disease progresses.

5 Nov 2025

New AI-assisted atlas can help visualize the human brain in unprecedented detail

A new AI-assisted brain atlas that can help visualize the human brain in unprecedented detail has been developed by UCL researchers, in a major step forward for neuroscience and neuroimaging.

5 Nov 2025

Study sheds light on how Alzheimer's disease may contribute to larger health issues

A recent study from Houston Methodist sheds light on how Alzheimer's disease may contribute to larger health issues by hijacking the body's ability to regulate its metabolism.

5 Nov 2025

Researchers reveal common synaptic pathway behind Parkinson’s and Alzheimer’s diseases

Parkinson's and Alzheimer's diseases are the two most common neurodegenerative disorders, affecting millions of people worldwide.

4 Nov 2025

Survival patterns differ across types of early-onset dementia

The survival rates of people with early onset dementia-diagnosed before the age of 65-vary considerably by clinical type, but sex, age, family history and co-existing conditions aren't specific risk factors, finds research published online in the Journal of Neurology Neurosurgery & Psychiatry.

4 Nov 2025

Free radicals generated at a specific site in astrocytes may promote dementia

Researchers have discovered that free radicals generated at a specific site in non-neuronal brain cells called astrocytes, may promote dementia, according to a Weill Cornell Medicine study.

4 Nov 2025

Small increases in daily steps may slow Alzheimer’s progression

Increasing your steps by even a little bit may help slow down the progression of Alzheimer's disease among people at heightened risk, according to a new study.

3 Nov 2025

Alzheimer's Disease News and Research

Further Reading

Muscle-driven gene therapy shows promise for protecting memory in Alzheimer’s

Scottish Brain Sciences opens new Alzheimer’s clinical research center at ONE Biohub

Hypertension may induce early gene expression changes in brain cells

New insights into glioblastoma survival linked to brain fluid dynamics

Empowering early detection of dementia with a dual approach involving AI and patient input

New Mayo Clinic tool predicts Alzheimer’s risk years before symptoms begin

What the air you breathe may be doing to your brain

Amyloid-clearing drug fails to change waste clearance function in the brains of Alzheimer's patients

Midlife blood test may reveal Alzheimer’s disease risk in advance

Shared genetic roots connect neurological and psychiatric disorders

Targeting RNA splicing errors protects against tau-induced neurodegeneration

Scientists pinpoint a reason Alzheimer’s patients forget loved ones

New diagnostic approach identifies dementia stages based on neurovascular and metabolic changes

Newly identified microglia subtype offers protection against Alzheimer’s disease

New AI-assisted atlas can help visualize the human brain in unprecedented detail

Study sheds light on how Alzheimer's disease may contribute to larger health issues

Researchers reveal common synaptic pathway behind Parkinson’s and Alzheimer’s diseases

Survival patterns differ across types of early-onset dementia

Free radicals generated at a specific site in astrocytes may promote dementia

Small increases in daily steps may slow Alzheimer’s progression

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News